HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong-Mei Liu Selected Research

Arginine (L-Arginine)

7/2015Hydrophobic Mutagenesis and Semi-rational Engineering of Arginine Deiminase for Markedly Enhanced Stability and Catalytic Efficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong-Mei Liu Research Topics

Disease

5Neoplasms (Cancer)
01/2022 - 07/2015
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2019 - 11/2011
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 06/2020
3Coronary Disease (Coronary Heart Disease)
01/2021 - 01/2019
3Myocardial Infarction
12/2020 - 06/2005
2Inflammation (Inflammations)
01/2020 - 06/2012
2Acquired Immunodeficiency Syndrome (AIDS)
08/2013 - 08/2013
2alpha-Thalassemia
09/2012 - 02/2008
2beta-Thalassemia (Cooley's Anemia)
02/2009 - 05/2006
2Hemolysis
04/2007 - 05/2006
1Pneumonia (Pneumonitis)
01/2021
1Cytokine Release Syndrome
01/2021
1Ventricular Remodeling
12/2020
1Fibrosis (Cirrhosis)
12/2020
1Epilepsy (Aura)
05/2019
1Squamous Cell Neoplasms (Squamous Cell Cancer)
05/2019
1Disease Progression
05/2019
1Neoplasm Metastasis (Metastasis)
01/2019
1Infarction (Infarctions)
09/2016
1Dehydration (Water Stress)
03/2014
1Brain Ischemia (Cerebral Ischemia)
06/2012
1Reperfusion Injury
06/2012
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2012
1Cardiovascular Diseases (Cardiovascular Disease)
06/2005
1Gangrene
06/2005
1Stroke (Strokes)
06/2005

Drug/Important Bio-Agent (IBA)

4Pharmaceutical PreparationsIBA
01/2021 - 08/2013
4yisui shengxueIBA
09/2012 - 05/2006
3SaponinsIBA
12/2020 - 01/2019
2Proteins (Proteins, Gene)FDA Link
10/2021 - 05/2006
2huoxue anxinIBA
01/2020 - 09/2016
2CollagenIBA
01/2020 - 09/2016
2ErbB Receptors (EGF Receptor)IBA
05/2019 - 01/2019
2Tyrosine Kinase InhibitorsIBA
01/2019 - 01/2017
1Biological ProductsIBA
01/2022
1Focal Adhesion Protein-Tyrosine KinasesIBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1Glucose Transporter Type 1IBA
10/2021
1XuebijingIBA
01/2021
1Huang QiIBA
01/2021
1Plant ExtractsIBA
01/2021
1CytokinesIBA
01/2021
1Therapeutic UsesIBA
01/2021
1p38 Mitogen-Activated Protein KinasesIBA
12/2020
1platycodin DIBA
06/2020
1oleananeIBA
06/2020
1TriterpenesIBA
06/2020
1Antiviral Agents (Antivirals)IBA
06/2020
1CholesterolIBA
01/2020
1osimertinibIBA
05/2019
1Gefitinib (Iressa)FDA Link
05/2019
1salicylhydroxamic acid (SHAM)IBA
09/2016
1MicroRNAs (MicroRNA)IBA
09/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2016
1Arginine (L-Arginine)FDA Link
07/2015
1arginine deiminaseIBA
07/2015
1propylene (propene)IBA
03/2014
1Liposomes (Liposome)IBA
02/2013
1Paclitaxel (Taxol)FDA LinkGeneric
02/2013
1AntioxidantsIBA
06/2012
1cordyminIBA
06/2012
1Peptides (Polypeptides)IBA
06/2012
1Neuroprotective AgentsIBA
06/2012
1Pemetrexed (MTA)FDA Link
11/2011
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2011
1PoisonsIBA
04/2007
1GlobinsIBA
04/2007
1Transcription Factors (Transcription Factor)IBA
05/2006
1alpha-GlobinsIBA
05/2006
1Hemoglobins (Hemoglobin)IBA
05/2006
1Lipoprotein(a)IBA
06/2005

Therapy/Procedure

2Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2020 - 02/2009
2Drug Therapy (Chemotherapy)
05/2019 - 11/2011
2Aftercare (After-Treatment)
08/2013 - 08/2013
1Radiotherapy
01/2019
1Surgical Amputation (Amputations)
06/2005
1Carotid Endarterectomy
06/2005